Location: Menlo Park, CA (on-site)

About Summit:

Ivonescimab, known as SMT112, is a novel, potential first-in-class investigational? bispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperative binding to each of its intended targets with multifold higher affinity when in the presence of both PD-1 and VEGF.

Summit has begun its clinical development of ivonescimab in non-small cell lung cancer (NSCLC), with three active Phase III trials:

• HARMONi is a Phase III clinical trial which intends to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a 3rd generation EGFR TKI (e.g., osimertinib).
• HARMONi-3 is a Phase III clinical trial which is designed to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
• HARMONi-7 is a Phase III clinical trial which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC whose tumors have high PD-L1 expression.

Ivonescimab is an investigational therapy that is not approved by any regulatory authority in Summit’s license territories, including the United States and Europe. Ivonescimab was approved for marketing authorization in China in May 2024. Ivonescimab was granted Fast Track designation by the US Food & Drug Administration (FDA) for the HARMONi clinical trial setting.

Overview of Role:

The Senior Manager, Regulatory Affairs CMC, is responsible for providing regulatory guidance on Chemistry, Manufacturing and Controls (CMC) regulatory activities for assigned product(s) in coordination with key internal stakeholders. This role will manage regulatory CMC aspects of compounds (large molecules) through all phases of development and provide strategic and operational management of preparation and maintenance of CMC regulatory filings to support on-going clinical activities as well as marketing applications.

?Role and Responsibilities:

• Represent Regulatory CMC in project teams and provide strategic regulatory CMC input to ensure successful product development
• Develop regulatory CMC strategies and manage CMC regulatory filings in US and ex-US clinical and marketing applications
• Manage internal review and approval process for CMC related submissions
• Coordinate the planning and preparation of Health Authority meeting requests, briefing books and responses to Health Authority information requests
• Manage timelines for assigned projects in alignment with company goals
• Review CMC sections of regulatory submissions (IND, IMPD, BLA etc.) for compliance with regulatory requirements and alignment with company strategies
• RA support in interactions with Health Authorities (HA), as appropriate
• Identify areas of continuous process improvement and engaging RA teams and key stakeholders as necessary
• Support in providing interpretation of global CMC regulations and guidelines, to Summit personnel for assigned programs
• Provide regulatory impact assessment to CMC changes and deviations and plan, prepare and manage any related regulatory submissions as necessary
• Escalate issues that affect regulatory compliance, promptly to CMC RA Management
• Maintain up to date knowledge of global regulations and guidance pertaining to CMC issues
• All other duties as assigned

Experience, Education and Specialized Knowledge and Skills:

• Bachelor's Degree in Chemistry, Pharmacy, Engineering, Biochemistry or related science required and Master's Degree or other advanced degree preferred
• A minimum of 5+Regulatory CMC experience and/ or related pharmaceutical industry experience required
• Experience in biologics required
• Thorough and extensive knowledge of FDA and EU regulations required
• Experience in preparation of CMC sections for regulatory submissions (IND, IMPD, BLA, MAA Amendments, Supplements etc.)
• A good understanding of IND, CTA, BLA and MAA processes
• Proficiency in Mandarin Chinese (spoken and written) is highly desirable
• Proficient user of standard of Office suite (e.g., Word, Excel), experience using electronic document management systems, and document review tools desirable
• Strong computer and database skills
• Attention to detail, accuracy and confidentiality
• Clear and concise oral and written communication skills
• Excellent organizational skills
• Critical thinking, problem solving, ability to work independently
• Must be able to effectively multi-task and manage time-sensitive and highly confidential documents
• Communicate effectively and articulate complex ideas in an easily understandable way
• Prioritize conflicting demands
• Work in a fast-paced, demanding and collaborative environment

The pay range for this role is $168,500-$190,000 annually. Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.